Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.

Slides:



Advertisements
Similar presentations
HIV Counseling, Testing and Referral (CTR) Services at Boston Medical Center Vanessa J. Sasso, MSW Manager, HIV CTR Program Center for HIV/AIDS Care and.
Advertisements

Sexually Transmitted Diseases Among Men Who Have Sex with Men: A need for new prevention and research strategies National Sexually Transmitted Disease.
Rapid HIV Testing and Its Role in Advancing HIV Prevention: 2004 Update Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers.
Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
Rapid HIV Testing: 2005 Update Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Division of HIV/AIDS Prevention.
CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
Version 11Page 1 of 6 Improving Identification of Patients Infected with HIV Using Rapid Testing in the Emergency Department: A Systems-Based Approach.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
HIV Testing in Health-Care Settings
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV TESTING AND DELIVERY PRELIMINARY POSITIVE HIV RESULT IN THE EMERGENCY DEPARTMENT TESTAZ PROGRAM AMY EDMONDS, MSW, LMSW PROGRAM COORDINATOR TESTAZ PROGRAM,
Rapid HIV Tests Norman Moore, Ph.D. Director of Medical Affairs.
Potential Role of Home-Use HIV Test Kits Bernard M. Branson, M.D. A ssociate Director for Laboratory Diagnostics Division of HIV/AIDS Prevention.
1 Annual Combustion Adjustment Electronic Reporting New Jersey Department of Environmental Protection.
Increasing Our Reach through Rapid HIV Testing Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers for Disease Control and.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV Testing in Health- Care Settings Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings U.S. Centers.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
HIV Screening: New Approaches and New Paradigms
HIV Screening and Women’s Health Health Care Education & Training, Inc. Originally developed by: Section 5: Test Options.
STD Testing Protocols, STD Testing, and Discussion of Sexual Behaviors in HIV Clinics in Los Angeles County Melanie M. Taylor MD, MPH Los Angeles County.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Rapid HIV Testing: 2003 Update Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers for Disease Control and Prevention.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis,
Implementing Rapid HIV Testing in the United States Bernard M. Branson, M.D. Centers for Disease Control and Prevention Overview and Background.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics
ABSTRACT Background: A retrospective medical record review was conducted to evaluate implementation of the Public Health Service recommendations for laboratory.
Universal HIV Testing Closing the Gap Peter A. Leone, MD Associate Professor of Medicine University of North Carolina Medical Director, NC HIV/STD Prevention.
*p
HIV Testing In Vermont Update 2007 Cathleen Harris, MD Fletcher Allen Health Care.
Click to edit Master title style Research Objective: The CDC estimates that 1 in 4 people living with HIV in the U.S. are unaware of their HIV status.
Rapid Testing in Emergency Departments: New Jersey Sindy M. Paul, MD, MPH, FACPM November 8, 2007.
Integration of Rapid HIV Testing in Sexually Transmitted Disease Clinics In New Jersey Sindy M. Paul 1, Evan M. Cadoff 2, Eugene G. Martin 2, Maureen Wolski.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis, STD,
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
ABSTRACT Background: The New Jersey Department of Health and Senior Services, Division of HIV/AIDS Services (NJDHSS, DHAS)) introduced rapid HIV testing.
John W. Hogan, M.D Howard University College of Medicine.
Rapid HIV Testing at Federally Qualified Health Care Centers in New Jersey Sindy M. Paul, M.D., M.P.H. 1, Eugene Martin, Ph.D. 2 Evan Cadoff, M.D. 2, Maureen.
Create & Submit Periodic Compliance Reports New Jersey Department of Environmental Protection.
1 OPA/OFP HIV Prevention Project Annual Technical Support Conference Six Years of HIV Supplemental Grants – A National Perspective Susan B. Moskosky Director,
The Division of Mental Health and Addiction Services (DMHAS) Rapid HIV Testing Initiative Update July 25, 2013.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
SSuN: MSM prevalence monitoring and HIV Testing in STD Clinics Kristen Mahle & Lori Newman SSuN Call #3 Oct 30, 2008.
HIV TESTING IN DRUG ABUSE TREATMENT James L. Sorensen, Ph.D. University of California, San Francisco and San Francisco General Hospital Presentation at.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
Introduction to OraQuick Rapid HIV Testing William F. Ryan Community Health Center School Based Health Program.
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
Annual Combustion Adjustment & Electronic Reporting New Jersey Department of Environmental Protection.
County Executive Congratulations! You are the County Executive. Your job is to research the demographics of the county. Scroll down to find your county.
Janet Lin, MD, MPH, Sweta Basnet, MS, Sara Baghikar, MD, Cammeo Mauntel-Medici, MPH, Sara Heinert, MPH University of Illinois at Chicago, College of Medicine,
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
Presenter Carolyn Tunstall, IPP Coordinator November 9, 2009 GC Prevention Activities In New Jersey.
ABSTRACT Purpose: Point-of-care rapid HIV testing is a new way to diagnose HIV disease. The New Jersey Department of Health and Senior Services Division.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
HIV Screening for Patients years: A Guide for TB Clinic Providers Best Practices in TB Control - August 28, Philip J. Peters, MD Medical Officer.
Historian Congratulations! You are the historian. It is your responsibility to learn about the history of your county. Scroll down to find your county.
Recreation Consultant
Presentation transcript:

Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention Centers for Disease Control and Prevention CDC’s Recommendations for HIV Screening in Health Care Settings The findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the Centers for Disease Control and Prevention

Number HIV infected 1,039,000 – 1,185,000 Number unaware of their HIV infection 252, ,000 (24%-27%) Estimated new infections 40,000 annually Defining the Problem: Persons with HIV, United States Glynn M, Rhodes P HIV Prevention Conference

HIV Testing in the United States % - 44% of US adults have been tested for HIV million persons age tested annually More than 75% of persons report they were tested for HIV in doctor’s offices, hospitals, or clinics Yet, 40% of persons reported with HIV receive an AIDS diagnosis within 1 year of their first HIV test – on average, 10 years after they first became infected (and infectious). - National Health Interview Survey, CDC HIV Surveillance Report, 2005

Reasons for testing: late versus early testers Supplement to HIV/AIDS Surveillance, MMWR June 27, 2003

Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings MMWR 2006;55(No. RR-14): Recommendations and Reports September 22, 2006

Revised Recommendations Adults and Adolescents - I Routine, voluntary HIV screening for all persons in health care settings, not based on risk All patients with TB or seeking treatment for STDs should be screened for HIV Repeat HIV screening of persons with known risk at least annually

Revised Recommendations Adults and Adolescents - II Opt-out HIV screening with the opportunity to ask questions and the option to decline testing Separate signed informed consent should not be required Prevention counseling in conjunction with HIV screening in health care settings should not be required

Rationale for Revising Recommendations Treatment Testing Transmission Developments related to:

Mortality and HAART Use Over Time HIV Outpatient Study, CDC, Patients on HAART Deaths per 100 PY -Palella et al, JAIDS 2006; 43:27.

Initial Focus: HIV Screening in Hospitals and Emergency Departments Cook County ED, Chicago2.3% Grady ED, Atlanta2.7% Johns Hopkins ED, Baltimore3.2% King-Drew Med Center ED, Los Angeles1.3% Inpatients, Boston Medical Center3.8% New HIV+Site  CDC studies and demonstration projects:

Uni-Gold Recombigen Multispot HIV-1/HIV-2 Reveal G3 OraQuick Advance Clearview Complete HIV 1/2 Clearview HIV ½ Stat Pak

Uni-Gold Recombigen Multispot HIV-1/HIV-2 Reveal G3 OraQuick Advance Clearview Complete HIV 1/2 Clearview HIV ½ Stat Pak

OraQuick Advance HIV-1/2 CLIA-waived for finger stick, whole blood, oral fluid Store at room temperature Screens for HIV-1 and 2 Read time minutes Shelf life: 6 months

Collect oral fluid specimens by swabbing gums with test device. Reduce hazards, facilitate testing in field settings

Positive Negative Reactive Control Positive HIV-1/2 Read results at 20 minutes

Uni-Gold Recombigen CLIA-waived for finger stick, whole blood Store at room temperature Screens for HIV-1 Read time minutes Shelf life: 1 year

Finger stick with disposable pipette

Add 1 drop specimen to well

Add 4 drops of wash solution

Read results in 10 minutes PositiveNegative

Clearview Complete HIV 1/2 Applied for CLIA waiver for whole blood Store at room temperature Screens for HIV-1 and 2 Read time minutes Shelf life: 2 years

Obtain Fingerstick blood sample

Insert barrel into buffer vial

Read results in 15 minutes

Clearview HIV-1/2 Stat-Pak Clia-waived for whole blood and fingerstick Store at room temperature Screens for HIV-1 and 2 Read time minutes Shelf life: 2 years

Obtain finger stick specimen…

Add 5 microliters specimen

Add 3 drops buffer to well

Read results in minutes PositiveNegative

Rationale for Revising Recommendations Treatment Testing Transmission Developments related to:

Knowledge of HIV Infection and Behavior Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the U.S. Marks G, et al. JAIDS. 2005;39:446 After people become aware they are HIV- positive, the prevalence of high-risk sexual behavior is reduced substantially. Reduction in Unprotected Anal or Vaginal Intercourse with HIV-neg partners: HIV-pos Aware vs. HIV-pos Unaware 68%

Awareness of Serostatus Among People with HIV and Estimates of Transmission ~25% Unaware of Infection ~75% Aware of Infection People Living with HIV/AIDS: 1,039,000- 1,185,000 New Sexual Infections Each Year: ~32,000 Accounting for: ~ % of New Infections ~ % of New Infections Marks, et al AIDS 2006;20:

Implementation: Examples

San Francisco Public Health Changed requirement for signed informed consent, May 2006 Compared rates of testing and new HIV diagnoses before and after change

20.6 HIV positive tests per month 30.6 HIV positive tests per month Trends in HIV Testing: San Francisco Public Health Zetola et al, JAMA March, 2007

HIV Testing Expansion Initiative New York City Health and Hospitals Corp Increase the number of patients who know their HIV status Increase testing from 50,000 per year to 100,000 per year in FY06

FY06: 72 Percent Increase in HIV Testing FY03 – FY05 Outpatient Only (Source: PLM) FY06 Outpatient, Inpatient and ED (Source: Facility Reports)

FY06: Number of HIV Positive Individuals More than Doubled FY03 – FY04 Outpatient Only (Source: PLM) FY05 Outpatient and ED Pilot Sites Only (Source: PLM and RHT in ED Pilot Project Reports) FY06 Outpatient, Inpatient and ED (Source: Facility Reports)

ED Rapid Testing, New Jersey Shaded: counties offer rapid testing Essex Sussex Burlington Atlantic Cumberland Salem Gloucester Camden Cape May Somerset Morris Bergen Passaic Warren Middlesex Hunterdon Union Hudson Monmouth Mercer Ocean NJ health department provides counselors, test kits 23 EDs now offer rapid HIV testing 10,628 tested through November 9, (2.6%) HIV positive

Fostering Implementation CDC: Six regional workshops for high-priority EDs National Medical Association: Work with primary care providers in 5 cities Gilead Sciences: Funding support for acute-care testing in 8 cities BaltimoreChicago Detroit MiamiNew York City Philadelphia San FranciscoWest Palm Beach

Summary There is an urgent need to increase the proportion of persons who are aware of their HIV-infection status Expanded, routine, voluntary, opt-out screening in health care settings is needed Revised recommendations: September 2006 Several jurisdictions have already begun